Vandoeuvre, France

Alexandre Bolotine

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 39(Granted Patents)


Location History:

  • Vandoeurve, FR (2012)
  • Vandoeuvre, FR (2006 - 2013)

Company Filing History:


Years Active: 2006-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Alexandre Bolotine

Introduction

Alexandre Bolotine is a notable inventor based in Vandoeuvre, France. He has made significant contributions to the field of gene expression monitoring, holding a total of 4 patents. His work has implications for both scientific research and practical applications in biotechnology.

Latest Patents

Bolotine's latest patents focus on methods for monitoring multiple gene expression. These inventions relate to techniques for assessing differential expression of a plurality of genes in a first cell compared to one or more second cells. The methods utilize microarrays containing genomic sequenced tags. Additionally, his patents encompass computer-readable media and computer-based systems, as well as substrates containing an array of genomic sequenced tags.

Career Highlights

Throughout his career, Bolotine has worked with prominent companies in the biotechnology sector, including Novozymes, Inc. and Novozymes A/S. His experience in these organizations has allowed him to develop and refine his innovative approaches to gene expression monitoring.

Collaborations

Some of Bolotine's notable coworkers include Randy M Berka and Ib Groth Clausen. Their collaborative efforts have contributed to advancements in the field of biotechnology and gene expression research.

Conclusion

Alexandre Bolotine's work in gene expression monitoring showcases his innovative spirit and dedication to advancing biotechnology. His patents and collaborations reflect a commitment to scientific progress and practical applications in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…